Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.54 |
| ▸ | MMP9 | P14780 | 5/20 | 0.53 |
| ▸ | MMP1 | P03956 | 4/20 | 0.53 |
| ▸ | MMP2 | P08253 | 4/20 | 0.53 |
| ▸ | MMP8 | P22894 | 4/20 | 0.53 |
| ▸ | NAMPT | P43490 | 1/20 | 0.51 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.50 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.50 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.50 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.50 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.50 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.50 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.47 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8838880 | 1.00 | MEN1 (0.54) | MEN1ALDH1A1KMT2AP2RX7MMP9 | |
| SCHEMBL29676862 | 1.00 | MEN1 (0.54) | MEN1ALDH1A1KMT2AP2RX7MMP9 | |
| SCHEMBL2442157 | 1.00 | MEN1 (0.54) | MEN1ALDH1A1KMT2AP2RX7MMP9 | |
| SCHEMBL8017602 | 1.00 | MEN1 (0.54) | MEN1ALDH1A1KMT2AP2RX7MMP9 | |
| SCHEMBL885306 | 1.00 | MEN1 (0.54) | MEN1ALDH1A1KMT2AP2RX7MMP9 | |
| SCHEMBL3328510 | 0.85 | NAMPT (0.52) | MEN1ALDH1A1KMT2AP2RX7MMP9 | |
| SCHEMBL5802535 | 0.85 | NAMPT (0.52) | MEN1ALDH1A1KMT2AP2RX7MMP9 | |
| SCHEMBL18141994 | 0.85 | NAMPT (0.52) | MEN1ALDH1A1KMT2AP2RX7MMP9 | |
| SCHEMBL1665424 | 0.85 | NAMPT (0.52) | MEN1ALDH1A1KMT2AP2RX7MMP9 | |
| SCHEMBL17923298 | 0.85 | NAMPT (0.52) | MEN1ALDH1A1KMT2AP2RX7MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230019032-A1 | BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2023-01-19 | — | — | US | disclosed |
| US-11001575-B1 | Benzolactam compounds as protein kinase inhibitors | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2021-05-11 | — | — | US | disclosed |
| US-10457669-B2 | Benzolactam compounds as protein kinase inhibitors | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2019-10-29 | — | — | US | disclosed |
| US-20190047990-A1 | BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2019-02-14 | — | — | US | disclosed |
| EP-2931724-B1 | PYRIDONEMORPHINAN ANALOGS AND BIOLOGICAL ACTIVITY ON OPIOID RECEPTORS | PURDUE PHARMA LP (US) | 2017-01-25 | — | — | EP | disclosed |
| US-9403824-B2 | Pyridonemorphinan analogs and biological activity on opioid receptors | PURDUE PHARMA L.P. (US) | 2016-08-02 | — | — | US | disclosed |
| US-9359317-B2 | Small molecule inhibitors of HIV proteases | PURDUE RESEARCH FOUNDATION (US) | 2016-06-07 | — | — | US | disclosed |
| US-9340542-B2 | Propellane-based compounds and the use thereof | PURDUE PHARMA L.P. (US) | 2016-05-17 | — | — | US | disclosed |
| US-20150203494-A1 | PYRIDONEMORPHINAN ANALOGS AND BIOLOGICAL ACTIVITY ON OPIOID RECEPTORS | PURDUE PHARMA L.P. | 2015-07-23 | — | — | US | disclosed |
| WO-2015097546-A1 | PROPELLANE-BASED COMPOUNDS AND THEIR USE AS OPIOID RECEPTOR MODULATORS | PURDUE PHARMA L.P. (US) | 2015-07-02 | — | — | WO | disclosed |
| US-8980906-B2 | Pyridonemorphinan analogs and biological activity on opioid receptors | PURDUE PHARMA L.P. (US) | 2015-03-17 | — | — | US | disclosed |
| US-20140187549-A1 | Pyridonemorphinan Analogs and Biological Activity on Opioid Receptors | PURDUE PHARMA L.P. (US) | 2014-07-03 | — | — | US | disclosed |
| WO-2014091295-A1 | PYRIDONEMORPHINAN ANALOGS AND BIOLOGICAL ACTIVITY ON OPIOID RECEPTORS | PURDUE PHARMA L.P. (US) | 2014-06-19 | — | — | WO | disclosed |
| US-20140135321-A1 | SMALL MOLECULE INHIBITORS OF HIV PROTEASES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2014-05-15 | — | — | US | disclosed |
| US-20110046199-A1 | SMALL MOLECULE INHIBITORS OF HIV PROTEASES | PURDUE RESEARCH FOUNDATION (US) | 2011-02-24 | — | — | US | disclosed |
| WO-2009091941-A1 | SMALL MOLECULE INHIBITORS OF HIV PROTEASES | PURDUE RESEARCH FOUNDATION (US) | 2009-07-23 | — | — | WO | disclosed |
| EP-0828848-B1 | PREPARATION OF HYDROXY COMPOUNDS BY BIOCONVERSION WITH DIOXYGENASE | AVECIA LTD (GB) | 2002-03-27 | — | — | EP | disclosed |
| US-6087137-A | PREPARING OPTICALLY ACTIVE COMPOUNDS FOR USE AS CHEMICAL INTERMEDIATES IN SYNTHESIS OF DRUGS AND AGRICULTURAL CHEMICALS ESPECIALLY ENZYME INHIBITORS TARGETED TO HUMAN IMMUNODEFICIENCY VIRUS | ZENECA LIMITED (GB) | 2000-07-11 | — | — | US | disclosed |
| EP-0828848-A1 | PREPARATION OF HYDROXY COMPOUNDS BY BIOCONVERSION WITH DIOXYGENASE | ZENECA LIMITED (GB) | 1998-03-18 | — | — | EP | disclosed |
| WO-1996037628-A1 | PREPARATION OF HYDROXY COMPOUNDS BY BIOCONVERSION WITH DIOXYGENASE | ZENECA LIMITED (GB) | 1996-11-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140187549-A1 | Pyridonemorphinan Analogs and Biological Activity on Opioid Receptors | OPRM1, OPRK1, OPRL1 | MEN1 4421/4885ALDH1A1 638/4885KMT2A 1981/4885 |
| US-20110046199-A1 | SMALL MOLECULE INHIBITORS OF HIV PROTEASES | SERPINB1, PRSS1, TMPRSS15 | MEN1 4536/4885ALDH1A1 3984/4885KMT2A 3601/4885 |
| US-20230019032-A1 | BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS | MAPK1, ALK, MAP3K1 | MEN1 1644/4885ALDH1A1 1598/4885KMT2A 968/4885 |
| US-20150203494-A1 | PYRIDONEMORPHINAN ANALOGS AND BIOLOGICAL ACTIVITY ON OPIOID RECEPTORS | OPRM1, OPRK1, OPRL1 | MEN1 4434/4885ALDH1A1 704/4885KMT2A 1879/4885 |
| US-20140135321-A1 | SMALL MOLECULE INHIBITORS OF HIV PROTEASES | SERPINB1, PRSS1, TMPRSS15 | MEN1 4536/4885ALDH1A1 3984/4885KMT2A 3601/4885 |
| US-20190047990-A1 | BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS | MAPK1, ALK, MAP3K1 | MEN1 1644/4885ALDH1A1 1598/4885KMT2A 968/4885 |
| US-11001575-B1 | Benzolactam compounds as protein kinase inhibitors | MAPK1, ALK, MAP3K1 | MEN1 1766/4885ALDH1A1 1601/4885KMT2A 997/4885 |
| US-10457669-B2 | Benzolactam compounds as protein kinase inhibitors | MAPK1, ALK, MAP3K1 | MEN1 1644/4885ALDH1A1 1598/4885KMT2A 968/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.